Company: NIVFW
Filing Date: 2025-01-31
Form Type: 6-K
Source: 0001213900-25-008566
Chunk: 1

Company: NewGenIvf Group Ltd
Filing Date: 2025-01-31
Form: 6-K
Chunk 1
---
.07 million to approximately 1.35 million. Every twenty (20) outstanding Class A Ordinary Shares will be combined into and automatically become one post-Reverse Stock Split Class A Ordinary Share. No fractional shares will be issued in connection with the Reverse Stock Split. Instead, the Company will issue one full post-Reverse Stock Split Class A Ordinary Share to any shareholder who would have been entitled to receive a fractional share as a result of the process.

After the Reverse Stock Split, all options, warrants and other convertible securities of the Company outstanding immediately prior to the Reverse Stock Split will be adjusted by dividing the number of Class A Ordinary Shares into which the options, warrants and other convertible securities are exercisable or convertible by twenty (20) in accordance with the terms of the plans, agreements or arrangements governing such options, warrants and other convertible securities and subject to rounding to the nearest whole share.

In connection with the Reverse Stock Split, the Company will amend and restate its memorandum and articles of association to reflect the adjustment of the number of authorized shares. Attached to this report on Form 6-K (this “Report”) as Exhibit 1.1 is a copy of such second amended and restated memorandum and articles of association, which will be effective on February 11, 2025.

Attached to this Report as Exhibit 99.1 is a copy of the press release dated January 31, 2025 titled “NewGenIvf Group Limited Announces Reverse Stock Split”.

<div align='center'>1

EXHIBIT INDEX</div>

| Exhibit 
 No.     |     | Description                                                 |
| 1.1     |     | Amended and Restated Memorandum and Articles of Association |
| 99.1    |     | Press release                                               |

<div align='center'>2

SIGNATURE</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: January 31, 2025

| NewGenIvf Group Limited |                                    |
| By:                     | /s/                                
 Wing Fung Alfred Siu               |
| Name:                   | Wing Fung Alfred Siu               |
| Title:                  | Chairman of the Board and Director |

<div align='center'>3</div>